UA112407C2 - Співкристали агомелатіну, спосіб їх виготовлення і фармацевтичні композиції, що їх містять - Google Patents
Співкристали агомелатіну, спосіб їх виготовлення і фармацевтичні композиції, що їх містятьInfo
- Publication number
- UA112407C2 UA112407C2 UAA201206840A UAA201206840A UA112407C2 UA 112407 C2 UA112407 C2 UA 112407C2 UA A201206840 A UAA201206840 A UA A201206840A UA A201206840 A UAA201206840 A UA A201206840A UA 112407 C2 UA112407 C2 UA 112407C2
- Authority
- UA
- Ukraine
- Prior art keywords
- crystals
- agomelatin
- manufacturing
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1101766A FR2976284B1 (fr) | 2011-06-09 | 2011-06-09 | Nouveaux co-cristaux d'agomelatine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
Publication Number | Publication Date |
---|---|
UA112407C2 true UA112407C2 (uk) | 2016-09-12 |
Family
ID=46690337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201206840A UA112407C2 (uk) | 2011-06-09 | 2012-06-05 | Співкристали агомелатіну, спосіб їх виготовлення і фармацевтичні композиції, що їх містять |
Country Status (6)
Country | Link |
---|---|
CN (1) | CN102816079B (fr) |
AP (1) | AP3198A (fr) |
CU (1) | CU20120086A7 (fr) |
FR (1) | FR2976284B1 (fr) |
HK (1) | HK1178881A1 (fr) |
UA (1) | UA112407C2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2810647A1 (fr) * | 2013-06-06 | 2014-12-10 | Zentiva, a.s. | Formulations pharmaceutiques, comprenant l'agomélatine sous forme d'un co-cristal de l'agomélatine avec un acide organique |
PT2810656T (pt) * | 2013-06-06 | 2017-11-13 | Zentiva As | Formulações de agomelatina compreendendo agomelatina na forma de cocristais |
EP3075724B1 (fr) * | 2015-03-31 | 2023-07-12 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Forme solide de l'agomélatine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE457089B (sv) * | 1986-02-05 | 1988-11-28 | Sandvik Ab | Saett att behandla en blandning av haardmetallkroppar foer att skilja dessa fraan varandra paa grundval av deras sammansaettningar och/eller strukturer |
FR2866335B1 (fr) * | 2004-02-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'agomelatine |
ES2379905T3 (es) * | 2007-02-27 | 2012-05-04 | Vertex Pharmceuticals Incorporated | Co-cristales y composiciones farmacéuticas que los comprenden |
-
2011
- 2011-06-09 FR FR1101766A patent/FR2976284B1/fr active Active
-
2012
- 2012-05-31 CU CU2012000086A patent/CU20120086A7/es unknown
- 2012-06-05 UA UAA201206840A patent/UA112407C2/uk unknown
- 2012-06-11 AP AP2012006308A patent/AP3198A/xx active
- 2012-06-11 CN CN201210191879.3A patent/CN102816079B/zh active Active
-
2013
- 2013-06-03 HK HK13106486.3A patent/HK1178881A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AP3198A (en) | 2015-03-31 |
CU20120086A7 (es) | 2014-01-29 |
FR2976284A1 (fr) | 2012-12-14 |
CN102816079A (zh) | 2012-12-12 |
HK1178881A1 (en) | 2013-09-19 |
FR2976284B1 (fr) | 2013-05-24 |
AP2012006308A0 (en) | 2012-06-30 |
CN102816079B (zh) | 2015-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201200728A1 (ru) | Новые сокристаллы агомелатина, способ их получения и фармацевтические композиции, которые их содержат | |
CY1120805T1 (el) | Κρυσταλλικες μορφες αναστολεα προλυλο υδροξυλασης | |
ECSP13012668A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
EA201300388A1 (ru) | Соединения замещенного бензамида | |
CR20140554A (es) | Compuestos de acido dimetil-benzoico | |
EA201690521A1 (ru) | Способ получения замещенных 5-фтор-1h-пиразолопиридинов | |
EA201391574A1 (ru) | Фармацевтически приемлемые сокристаллы n-[2-(7-метокси-1-нафтил)этил]ацетамида и способы их получения | |
CL2011001405A1 (es) | Procedimiento para la preparacion de n-[2-(7-metoxi-1-naftil)etil]acetamida, agometalina. | |
BR112012014683A2 (pt) | processo para a produção de derivados de ácido 1-alquil/1-aril-5-pirazolcarboxílico | |
UA112407C2 (uk) | Співкристали агомелатіну, спосіб їх виготовлення і фармацевтичні композиції, що їх містять | |
MX2014013761A (es) | Acidos (3r,4r,5s)-5-guanidino-4-acetamido-3-(pentan-3-iloxi)cicloh exen-1-carboxilicos fluorosustituidos, sus esteres y uso de los mismos. | |
CU20120087A7 (es) | Procedimiento de síntesis y forma cristalina del hidrocloruro de 4-(3-(cis-hexahidrociclopenta(c)pirrol-2(1h)-il)propoxi)benzamida así como las composiciones farmacéuticas que la contienen | |
BR112014009760A2 (pt) | análogos de ácido siálico, seu uso e composição farmacêutica e composição farmacêutica de liberação sustentada os compreendendo | |
ES2403549R1 (es) | Co-cristales de agomelatina con formadores de co-cristales | |
EA201400365A1 (ru) | Новые тиопроизводные лактамов в качестве высокоактивных ингибиторов hdac и их применение в качестве лекарственных средств | |
AR080150A1 (es) | Utilizacion de la agomelatina para la obtencion de medicamentos destinados al tratamiento del trastorno obsesivo compulsivo (toc) | |
FR2990134B1 (fr) | Composition pharmaceutique d'un inhibiteur du virus du papillome | |
CR20130300A (es) | Nuevo procedimiento de síntesis de la agomelatina | |
MD20160072A2 (ro) | Procedeu nou de sinteză a 7-metoxi-naftalină-1-carbaldehidei şi aplicarea acesteia în sinteza agomelatinei | |
TH1701003364A (th) | กรด 3-(6-แอลคอกซี-5-คลอโรเบนโซ[d]ไอซอกซาโซล-3-อิล) โพรพาโนอิกที่มีประโยชน์ในฐานะสารยับยั้งไคนูเรนีนโมโนออกซีจีเนส | |
TH138902A (th) | ผลึกร่วมแบบใหม่ของอะโกเมลาทีน กระบวนการในการเตรียมสารดังกล่าวและองค์ประกอบทางเภสัชกรรมที่ประกอบด้วยสารดังกล่าว | |
UA109028C2 (en) | 2-HETARYL-2- (1,3-DIGIDRO-1-ISOBENZOFURANILIDEN) ACETONITRILES AND THE METHOD OF OBTAINING THEM | |
CR11459A (es) | Un nuevo proceso para la sintesis y la nueva formula cristalina de agomelatina y los compuestos farmaceuticos que la contienen | |
UA110478C2 (ru) | 3-моноетаноламіносукциноїламідо-n-(3',4'-диметилфеніл)антранілова кислота, що проявляє протизапальну, анальгетичну, діуретичну та протигрибкову активність | |
BR112015023592A2 (pt) | compostos orgânicos |